Skip to main content

Table 1 Adaptations in the National Immunization Programme (NIP) in the Netherlands from 2006 to 2018

From: Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands

Year

Vaccination

Adaptation in the Dutch NIP

2018

Meningococcal ACWY vaccination

Change from MenC conjugate vaccine administered at 14 months of age to MenACWY conjugate vaccine.

2014

Human Papillomavirus vaccination

Change from 3 vaccinations to 2 vaccinations administered at 12 years of age.

2013

Pneumococcal vaccination

Change from 4 vaccinations administrated at 2, 3, 4 and 11 months of age to 3 vaccinations at 2, 4 and 11 months.

2011

Hepatitis B vaccination

Change from vaccination offered to infants at risk to vaccination for all children administered at 2, 3, 4 and 11 months of age, via DTaP-IPV-Hib-HepB.

2011

Pneumococcal vaccination

Change from vaccination against 7 serotypes to vaccination against 10 serotypes.

2009

Human Papillomavirus vaccination

Introduction of vaccination for girls 12 years of age with catch-up for girls up to 17 years of age.

2006

Pneumococcal vaccination

Introduction of vaccination administered at 2, 3, 4 and 11 months of age, simultaneously with DTaP-IPV-Hib-(HepB).